Business
SANUWAVE Health, Inc. Announces Successful Results of Annual Meeting of Stockholders
SUWANEE, GA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE” or the “Company”) today announced the
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"SUWANEE, GA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE” or the “Company”) today announced the results from the Company’s 2020 Annual Meeting of Stockholders, held Thursday, July 23, 2020.\n All director nominees, including Kevin A. Richardson II, John F. Nemelka, Alan L Rubino, A. Michael Stolarski, Maj-Britt Kaltoft, and Thomas Price were elected to the Company’s board of directors. Stockholders also approved the ratification of the appointment of Marcum LLP as the Company’s independent public accounting firm for the fiscal year ending December 31, 2020; the reincorporation of the Company from the State of Nevada to the State of Delaware; an amendment to the Company’s articles of incorporation to increase the number of authorized shares of the Company’s common stock by 250 million shares to 600 million shares; the grant of authority to the Company’s board of directors to effect a reverse split of the Company’s outstanding common stock at a ratio of between 1-for-10 and 1-for-50; and, on an advisory basis, the executive compensation of the Company’s named executive officers, commonly known as “say-on-pay.” In addition, the stockholders voted, on an advisory basis, to hold a “say-on-pay” vote at a frequency of once every three years. “SANUWAVE is extremely pleased with the outcome of our Annual Meeting of Stockholders,” stated Kevin A. Richardson II, the Company’s Chief Executive Officer. “With our stockholders’ approval, as reflected at the Annual Meeting, we intend to transform SANUWAVE. We expect to soon accomplish the reincorporation by converting to a Delaware corporation. Further, we expect to use some of the additional authorized shares to help complete the purchase of Celularity’s UltraMIST assets and partnership rights for its wound care biologic products. In the near future, the Company expects to file an application to have its securities listed on Nasdaq. We want to thank our stockholders for their ongoing support.” The Company has filed a Current Report on Form 8-K with the SEC (https://www.sec.gov/Archives/edgar/data/1417663/000165495420007965/0001654954-20-007965-index.htm) reporting the results of the 2020 Annual Meeting. About SANUWAVE Health, Inc. SANUWAVE Health, Inc. (OTCQB:SNWV) (www.SANUWAVE.com) is a shockwave technology company initially focused on...